Hanson Wade have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topics.
Join the 14th HPAPI: Highly Potent Drug Manufacturing Summit – the premier event dedicated to highly potent active pharmaceutical ingredient manufacturing, cytotoxic compound development, and process safety. For the first time, this flagship event is free* for drug developers!
Why Attend the HPAPI Summit in 2025?
With the global highly potent drug market expected to reach $46.9 billion by 2030, the demand for advanced drug delivery, personalized medicine, and oncology innovations continues to grow. This summit is your gateway to the latest strategies in handling small molecules, conjugates, and other targeted therapies.
Register now to join this exclusive gathering of HPAPI leaders and innovators to:
- Secure the right CDMO partner
- Streamline process development
- Enhance containment and worker safety
*Free for drug developers — Subject to T&Cs.
What to Expect at This Year’s Event
Held in Boston, the 2025 HPAPI Manufacturing Summit features a revamped agenda including:
- Real-world case studies on cytotoxic compound development
- Insights into cross-functional collaboration and process optimization
- Strategies for safe scale-up and occupational health
Who Will You Meet?
Network with 60+ senior leaders in:
- CMC (Chemistry, Manufacturing, and Controls)
- Technical Operations
- Process Chemistry & Engineering
- Drug Substance & Drug Product Development
- Environmental, Health & Safety (EHS)
- Industrial Hygiene
Featured Organizations
Hear from expert speakers representing top global pharma companies including: Pfizer | Bristol Myers Squibb | Johnson & Johnson | Biogen | Teva Pharmaceuticals | Relay Therapeutics
2025 Expert Speakers Include:
Join attendees from top pharma leaders including:
2025 Partners:
